Gene: C14orf178
Official Full Name: SLIRP overlapping transcript 1provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19183 | C14orf178 Knockout cell line (HeLa) | Human | C14orf178 | 1:3~1:6 | Negative | Online Inquiry |
KO19184 | C14orf178 Knockout cell line (HCT 116) | Human | C14orf178 | 1:2~1:4 | Negative | Online Inquiry |
KO19185 | C14orf178 Knockout cell line (HEK293) | Human | C14orf178 | 1:3~1:6 | Negative | Online Inquiry |
KO19186 | C14orf178 Knockout cell line (A549) | Human | C14orf178 | 1:3~1:4 | Negative | Online Inquiry |
C14orf178 Gene Knockout Cell Lines are genetically engineered cell lines featuring targeted deletions of the C14orf178 gene, which is implicated in various cellular processes, including cell cycle regulation and apoptosis. By precisely knocking out this gene, researchers can investigate the specific biological functions attributed to C14orf178 and its role in disease mechanisms, including cancer and metabolic disorders.
The key function of these cell lines lies in their ability to emulate loss-of-function scenarios of the C14orf178 gene, allowing for the examination of downstream signaling pathways and potential compensatory mechanisms activated in the absence of this gene. The selected cell lines are validated for efficient knockout via CRISPR/Cas9 technology, ensuring high specificity and minimal off-target effects, thereby providing robust models for subsequent research.
The scientific importance of C14orf178 Gene Knockout Cell Lines is underscored by their utility in both basic and applied research settings. These models facilitate the study of gene function in a controlled environment, paving the way for discoveries related to gene expression, protein interactions, and therapeutic targets. In clinical research, they may aid in the development of precision medicine approaches by elucidating the role of C14orf178 in patient-derived samples.
What sets our C14orf178 Gene Knockout Cell Lines apart from alternative models is their comprehensive validation and optimizing characteristics, including user-friendly protocols for maintenance and experimental manipulation. These cell lines offer researchers the capacity to explore the intricacies of cellular pathways with confidence, as well as produce reproducible and translatable results.
For researchers and clinicians, the value of C14orf178 Gene Knockout Cell Lines lies in their potential to unravel complex genetic networks and contribute essential insights for therapeutic advancements. Our company prides itself on a deep understanding of genetic engineering and cellular biology, ensuring that our products are at the forefront of scientific innovation. We are dedicated to supporting cutting-edge research with high-quality, reliable biological products tailored to meet the needs of our customers in both academic and clinical settings.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.